Developing a multi-domain EHR foundation model for predicting Hepatitis B liver disease: a clinical perspective
Caroline Weis(GlaxoSmithKline (India)), Patrick Schwab, Jonathan L. Golob(University of Michigan), Max Horn(SIB Swiss Institute of Bioinformatics), Adam Kania(GlaxoSmithKline (India)), Giovanni Visonà(GlaxoSmithKline (India)), Filippo Grazioli(GlaxoSmithKline (India)), Max F. Burg(GlaxoSmithKline (India))
Cited by 0
Related Papers
Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning
|Nature Medicine|2022|269
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review
|Clinical Microbiology and Infection|2020|214
Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis
|Travel Medicine and Infectious Disease|2020|155
Machine Learning for Toxicity Prediction Using Chemical Structures: Pillars for Success in the Real World
|Chemical Research in Toxicology|2025|99
Phylogenetic Tools for Generalized HIV-1 Epidemics: Findings from the PANGEA-HIV Methods Comparison
|Molecular Biology and Evolution|2016|71